Rod Lauzon

Rod Lauzon is an accomplished executive at AstraZeneca, serving as the Executive Director of U.S. Respiratory & Immunology Market Access Strategy and the Commercial Lead for Symbicort since 2005. With extensive experience in market access strategy, managing a $2B+ portfolio, Lauzon has directed initiatives across payer marketing, contracting, and revenue management, achieving significant milestones, including over $1B in revenue savings through the implementation of the 340B Contract Pharmacy Policy. Previous roles at AstraZeneca include Senior Director of Market Access Operations and Director of Aseptic Filling Operations, where Lauzon successfully led cross-functional teams and transformed operations. Prior experience includes a leadership position at Merck overseeing vaccine production and a Quality Assurance Manager role at Quest Diagnostics. Lauzon holds a Bachelor of Science in Clinical Laboratory Science from the University of Delaware.